1-2 of 2
L. James Lee, Ph.D
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Therapeutic Targeting of the RAS-Pathway by Synthetic Mir-181a Nanoparticles in Acute Myeloid Leukemia (AML).

Xiaomeng Huang, Sebastian Schwind, MD, Ann-Kathrin Eisfeld, MD, Bo Yu, Ph.D, Ramasamy Santhanam, Ph.D, Pia Hoellerbauer, Yan Jin, Ph.D, Christopher Hickey, Ph.D, Jiuxia Pang, Kenneth K. Chan, Ph.D, Danilo Perrotti, MD, Ph.D, Natarajan Muthusamy, DVM, Ph.D, John C. Byrd, MD, William Blum, MD, Clara D. Bloomfield, MD, Shujun Liu, Ph.D, Ramiro Garzon, MD, Robert J. Lee, Ph.D, L. James Lee, Ph.D, Guido Marcucci, MD
Journal: Blood
Blood (2012) 120 (21): 2422.
https://doi.org/10.1182/blood.V120.21.2422.2422
Published: 2012
Journal Articles

Targeted Delivery of MicroRNA-29b by Nanoparticles Provides Antileukemic Activity and Increases Sensitivity to the Hypomethylating Agent Decitabine (DAC) in Acute Myeloid Leukemia (AML)

Xiaomeng Huang, Sebastian Schwind, MD, Bo Yu, Ph.D, Jiuxia Pang, Ramasamy Santhanam, Ph.D, Kenneth K. Chan, Ph.D, Ramiro Garzon, MD, William Blum, MD, Clara D. Bloomfield, MD, Shujun Liu, Ph.D, Danilo Perrotti, MD, Ph.D, Robert J. Lee, Ph.D, John C. Byrd, MD, Natarajan Muthusamy, DVM, Ph.D, L. James Lee, Ph.D, Guido Marcucci, MD
Journal: Blood
Blood (2011) 118 (21): 81.
https://doi.org/10.1182/blood.V118.21.81.81
Published: 2011